Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2013 (2013), Article ID 109837, 9 pages
http://dx.doi.org/10.1155/2013/109837
Research Article

Preparation and Comparative Bioavailability Studies of Indomethacin-Loaded Cetyl Alcohol Microspheres

Department of Pharmaceutics, JSS College of Pharmacy, JSS University, Sri Shivarathreeshwara Nagar, Karnataka, Mysore 570015, India

Received 3 June 2012; Revised 12 August 2012; Accepted 15 August 2012

Academic Editor: Nayanabhirama Udupa

Copyright © 2013 N. Vishal Gupta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Brannon-Peppas, “Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery,” International Journal of Pharmaceutics, vol. 116, no. 1, pp. 1–9, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Karasulu, H. Yeşim Karasulu, G. Ertan, L. Kirilmaz, and T. Güneri, “Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates,” European Journal of Pharmaceutical Sciences, vol. 19, no. 2-3, pp. 99–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Rowe, P. J. Sheskey, and M. Quinn, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, London, UK, 5th edition, 2005.
  4. M. Brien, J. McCauley, and E. Cohen, “Indomethacin,” in Analytical Profiles of Drug Substances, K. Florey, Ed., pp. 211–238, Academic Press, London, UK, 2005. View at Google Scholar
  5. M. Bogdan, A. Pirnau, C. Floare, and C. Bugeac, “Binding interaction of indomethacin with human serum albumin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 47, no. 4-5, pp. 981–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Amir and S. Kumar, “Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives,” Archiv der Pharmazie, vol. 338, no. 1, pp. 24–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Tamilvanan and B. Sa, “Studies on in vitro release behaviour of indomethacin-loaded polystyrene microparticles,” International Journal of Pharmaceutics, vol. 201, no. 2, pp. 187–197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. D. B. Myers, K. Wilson, and D. G. Palmer, “An objective measurement of change in morning stiffness,” Rheumatology International, vol. 1, no. 3, pp. 135–137, 1981. View at Google Scholar · View at Scopus
  9. S. Salib, S. Donney, and D. Doyle, “Therapy and drugs in the control of osteo arthritis,” Prescr, vol. 8, pp. 41–59, 1996. View at Google Scholar
  10. D. V. Gowda and H. G. Shivakumar, “Encapsulation of theophylline into waxes /fat microspheres, preparation, characterization & release kinetics,” Hamdard Medicus, vol. 50, pp. 69–81, 2007. View at Google Scholar
  11. L. I. Giannola, V. De Caro, and A. Severino, “Carnauba wax microspheres loaded with valproic acid: preparation and evaluation of drug release,” Drug Development and Industrial Pharmacy, vol. 21, no. 13, pp. 1563–1572, 1995. View at Google Scholar · View at Scopus
  12. D. V. Gowda and H. G. Shivakumar, “Encapsulation of griseofulvin in waxes/ fat microspheres: preparation, characterization and release kinetics of microspheres,” Indian Drugs, vol. 42, no. 7, pp. 453–460, 2005. View at Google Scholar · View at Scopus
  13. E. J. Parish, T. L. Boos, and S. Li, “The chemistry of waxes and sterols,” in Food Lipids: Chemistry, Nutrition, and Biochemistry, C. C. Akoh and D. B. Min, Eds., Marcel Dekker, New York, NY, USA, 2nd edition, 2002. View at Google Scholar
  14. D. V. Gowda and H. G. Shivakumar, “Comparative bioavailability studies of indomethacin from two-controlled release formulations in healthy albino sheep,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 6, pp. 760–763, 2006. View at Google Scholar · View at Scopus
  15. D. V. Gowda, B. Girish, H. G. Shivakumar, and A. Moin, “Preparation and evaluation of carnauba wax microspheres loaded with aceclofenac for controlled release,” Indian Journal of Pharmaceutical Education and Research, vol. 42, no. 4, pp. 329–336, 2008. View at Google Scholar · View at Scopus
  16. United State Pharmacopoeia 24/National formulary 19, United State Pharmacopoeial Convention, Rockville, Md, USA, 1999.
  17. A. G. Johnson and J. E. Roy, “Improved HPLC method for the determination of indomethacin in plasma,” Therapeutic Drug Monitoring, vol. 14, pp. 61–65, 1992. View at Publisher · View at Google Scholar
  18. E. Pascual and F. Sivera, “Therapeutic advances in gout,” Current Opinion in Rheumatology, vol. 19, no. 2, pp. 122–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Food and Drug administration, Division of biopharmaceutics, Bioavailability and NDA submission regulations, 1977.
  20. FDA Guidelines for Industry, “Extended release oral dosage form evaluation and application for in vitro- in vivo correlation,” Dissolution Technologies, vol. 4, pp. 23–31, 1997. View at Google Scholar